• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单分散壳聚糖纳米粒子对 Caco-2 细胞的细胞毒性。

Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells.

机构信息

Laboratory for Drug Delivery, Pharmacy, Characterisation and Analysis, University of Western Australia, Australia.

出版信息

Toxicol Appl Pharmacol. 2012 Aug 1;262(3):273-82. doi: 10.1016/j.taap.2012.04.037. Epub 2012 May 18.

DOI:10.1016/j.taap.2012.04.037
PMID:22609640
Abstract

Published toxicology data on chitosan nanoparticles (NP) often lack direct correlation to the in situ size and surface characteristics of the nanoparticles, and the repeated NP assaults as experienced in chronic use. The aim of this paper was to breach these gaps. Chitosan nanoparticles synthesized by spinning disc processing were characterised for size and zeta potential in HBSS and EMEM at pHs 6.0 and 7.4. Cytotoxicity against the Caco-2 cells was evaluated by measuring the changes in intracellular mitochondrial dehydrogenase activity, TEER and sodium fluorescein transport data and cell morphology. Cellular uptake of NP was observed under the confocal microscope. Contrary to established norms, the collective data suggest that the in vitro cytotoxicity of NP against the Caco-2 cells was less influenced by positive surface charges than by the particle size. Particle size was in turn determined by the pH of the medium in which the NP was dispersed, with the mean size ranging from 25 to 333 nm. At exposure concentration of 0.1%, NP of 25 ± 7 nm (zeta potential 5.3 ± 2.8 mV) was internalised by the Caco-2 cells, and the particles were observed to inflict extensive damage to the intracellular organelles. Concurrently, the transport of materials along the paracellular pathway was significantly facilitated. The Caco-2 cells were, however, capable of recovering from such assaults 5 days following NP removal, although a repeat NP exposure was observed to produce similar effects to the 1st exposure, with the cells exhibiting comparable resiliency to the 2nd assault.

摘要

已发表的壳聚糖纳米颗粒(NP)的毒理学数据通常与原位大小和纳米颗粒的表面特性缺乏直接相关性,也无法反映慢性使用中重复 NP 攻击的情况。本文旨在弥补这些空白。通过旋转圆盘处理合成的壳聚糖纳米颗粒,在 HBSS 和 EMEM 中于 pH 值 6.0 和 7.4 下进行粒径和 Zeta 电位的特征分析。通过测量细胞内线粒体脱氢酶活性、TEER 和荧光素钠转运数据以及细胞形态的变化,评估 NP 对 Caco-2 细胞的细胞毒性。通过共聚焦显微镜观察 NP 的细胞摄取情况。与既定规范相反,综合数据表明,NP 对 Caco-2 细胞的体外细胞毒性受正表面电荷的影响小于受粒径的影响。粒径又取决于 NP 分散的介质的 pH 值,平均粒径范围为 25 至 333nm。在暴露浓度为 0.1%时,粒径为 25±7nm(Zeta 电位 5.3±2.8mV)的 NP 被 Caco-2 细胞内化,并且观察到颗粒对细胞内细胞器造成广泛损伤。同时,沿着细胞旁途径的物质转运明显得到促进。然而,NP 去除后 5 天,Caco-2 细胞能够从这些攻击中恢复,尽管重复 NP 暴露会产生类似于第 1 次暴露的效果,细胞对第 2 次攻击表现出类似的恢复能力。

相似文献

1
Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells.单分散壳聚糖纳米粒子对 Caco-2 细胞的细胞毒性。
Toxicol Appl Pharmacol. 2012 Aug 1;262(3):273-82. doi: 10.1016/j.taap.2012.04.037. Epub 2012 May 18.
2
Adsorption of hematite nanoparticles onto Caco-2 cells and the cellular impairments: effect of particle size.赤铁矿纳米粒子在 Caco-2 细胞上的吸附及细胞损伤:粒径的影响。
Nanotechnology. 2010 Sep 3;21(35):355103. doi: 10.1088/0957-4484/21/35/355103. Epub 2010 Aug 9.
3
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.壳聚糖及其衍生物的渗透促进作用:作为可溶性聚合物和纳米颗粒系统的制剂对Caco-2细胞中胰岛素吸收的比较。
Eur J Pharm Biopharm. 2008 Sep;70(1):270-8. doi: 10.1016/j.ejpb.2008.03.004. Epub 2008 Mar 12.
4
Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.壳聚糖/聚γ-谷氨酸纳米颗粒的制备及其通过Caco-2细胞的渗透性评估。
Biomacromolecules. 2005 Mar-Apr;6(2):1104-12. doi: 10.1021/bm049312a.
5
Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.载有褪黑素的卵磷脂/壳聚糖纳米粒:理化特性及通过 Caco-2 细胞单层的渗透性。
Int J Pharm. 2009 Nov 3;381(2):205-13. doi: 10.1016/j.ijpharm.2009.07.001. Epub 2009 Jul 9.
6
Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.新型载蛋白硫酸软骨素-壳聚糖纳米粒的制备与表征。
Acta Biomater. 2011 Oct;7(10):3804-12. doi: 10.1016/j.actbio.2011.06.026. Epub 2011 Jun 24.
7
Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.聚合物两亲性纳米粒作为口服药物载体的生物相容性、细胞摄取和体内分布。
Colloids Surf B Biointerfaces. 2013 Mar 1;103:345-53. doi: 10.1016/j.colsurfb.2012.11.012. Epub 2012 Nov 29.
8
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.壳聚糖纳米颗粒在体外与呼吸道上皮细胞具有相容性。
Eur J Pharm Sci. 2007 Jun;31(2):73-84. doi: 10.1016/j.ejps.2007.02.008. Epub 2007 Feb 25.
9
Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.壳聚糖/PLGA 纳米粒胶体稳定性与其细胞毒性特征的相关性。
Int J Pharm. 2009 Nov 3;381(2):130-9. doi: 10.1016/j.ijpharm.2009.04.049. Epub 2009 May 18.
10
Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.叶酸偶联 N-三甲基壳聚糖纳米粒作为蛋白载体靶向叶酸受体的制备及表征:体外研究。
J Drug Target. 2009 May;17(4):294-303. doi: 10.1080/10611860902737920.

引用本文的文献

1
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
2
Chitosan as an Antimicrobial, Anti-Insect, and Growth-Promoting Agent for Potato ( L.) Plants.壳聚糖作为一种抗菌、抗虫和促进马铃薯(L.)植物生长的物质。
Molecules. 2024 Jul 13;29(14):3313. doi: 10.3390/molecules29143313.
3
Chitosan Nanoparticles-Preparation, Characterization and Their Combination with Extract in Preliminary In Vitro Studies.
壳聚糖纳米粒子的制备、表征及其与提取物的结合在初步的体外研究中。
Molecules. 2023 Jun 23;28(13):4950. doi: 10.3390/molecules28134950.
4
Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review.纳米级药物载体的形态和尺寸对细胞摄取及内化过程的影响:综述
RSC Adv. 2022 Dec 20;13(1):80-114. doi: 10.1039/d2ra06888e. eCollection 2022 Dec 19.
5
The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles.壳聚糖在纳米医学中的潜力:基于壳聚糖的纳米颗粒细胞毒性概述
Front Pharmacol. 2022 May 4;13:880377. doi: 10.3389/fphar.2022.880377. eCollection 2022.
6
Toxicological Aspects of Iron Oxide Nanoparticles.铁氧化物纳米颗粒的毒理学方面。
Adv Exp Med Biol. 2022;1357:303-350. doi: 10.1007/978-3-030-88071-2_13.
7
Assessing the Biocompatibility of Multi-Anchored Glycoconjugate Functionalized Iron Oxide Nanoparticles in a Normal Human Colon Cell Line CCD-18Co.评估多锚定糖缀合物功能化氧化铁纳米颗粒在正常人结肠细胞系CCD-18Co中的生物相容性。
Nanomaterials (Basel). 2021 Sep 22;11(10):2465. doi: 10.3390/nano11102465.
8
Dual-Acting Zeta-Potential-Changing Micelles for Optimal Mucus Diffusion and Enhanced Cellular Uptake after Oral Delivery.用于口服给药后实现最佳黏液扩散和增强细胞摄取的双功能ζ电位变化胶束。
Pharmaceutics. 2021 Jun 27;13(7):974. doi: 10.3390/pharmaceutics13070974.
9
Biocompatibility analysis of high molecular weight chitosan obtained from shrimps. Evaluation in prokaryotic and eukaryotic cells.从虾中提取的高分子量壳聚糖的生物相容性分析。在原核细胞和真核细胞中的评估。
Biochem Biophys Rep. 2020 Nov 12;24:100842. doi: 10.1016/j.bbrep.2020.100842. eCollection 2020 Dec.
10
Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro.自乳化药物传递系统:疏水性药物聚合物复合物在体外提供持续释放。
Mol Pharm. 2020 Oct 5;17(10):3709-3719. doi: 10.1021/acs.molpharmaceut.0c00389. Epub 2020 Sep 5.